Public Health Emergency of International Concern (PHEIC)
Weekly Epidemiological and Operational updates
last update: 8 October 2020, 20:00 GMT-4
Confirmed cases :: 39 023 292 [week ago: 36 754 395 :: two weeks ago: 34 495 176]
Confirmed deaths :: 1 099 586 [week ago 1 064 838 :: two weeks ago: 1 025 729]
Countries, areas or territories with cases :: 235
WHO Director-General’s opening remarks at the media briefing on COVID-19 – 16 October 2020
16 October 2020
:: Interim results from the Solidarity Therapeutics Trial now show that the other two drugs in the trial, remdesivir and interferon, have little or no effect in preventing death from COVID-19 or reducing time in hospital.
:: For the moment, the corticosteroid dexamethasone is still the only therapeutic shown to be effective against COVID-19, for patients with severe disease.
:: Although the number of deaths reported in Europe last week is much lower than in March, hospitalizations are increasing and many cities are reporting they will reach their intensive care bed capacity in the coming weeks.
:: During this year’s southern hemisphere winter, the number of seasonal flu cases and deaths was less than usual because of the measures put in place to contain COVID-19. But we cannot assume the same will be true in the northern hemisphere flu season.
:: Demand for influenza vaccines may outstrip supply in some countries. The Strategic Advisory Group of Experts on Immunization has therefore recommended that, among the five risk groups, health workers and older adults are the highest priority groups for influenza vaccination during the COVID-19 pandemic. Another under-utilized tool is the use of antivirals to treat people with influenza. We encourage all countries to use all the tools at their disposal.
:: Today is World Hypertension Day. To support countries to take action against cardiovascular diseases, WHO has developed the HEARTS package, which outlines the six key ingredients for addressing threats to heart health, including hypertension.
Weekly Epidemiological Update
Coronavirus disease 2019 (COVID-19)
12 October 2020
Global epidemiological situation
Since the last Weekly Epidemiological Update issued on 5 October, over 2.2 million new cases and 39,000 deaths of COVID-19 have been reported across all six WHO regions. This is the highest number of reported cases so far in a single week.
From 30 December through 11 October, over 37 million COVID-19 cases and 1 million deaths have been reported globally. Nearly half of these cases (48%) and deaths (55%) continue to be reported in the Region of the Americas with the United States of America, Brazil and Argentina accounting for the greatest numbers of new cases and deaths in the region…
Key weekly updates
At WHOs Executive Board meeting, WHO Director-General Dr Tedros highlighted some of WHO’s key actions over the course of the pandemic:
:: Publishing the first Strategic Preparedness and Response Plan 4 days later;
:: Producing and shipping the diagnostic tests within a month of declaring the outbreak, with millions of tests distributed to more than 150 countries since then;
:: Publishing more than 400 guidance documents for individuals, communities, schools, businesses, industries, health workers, health facilities and governments;
:: Building country capacity by providing free training in 133 COVID-19 courses on OpenWHO.org;
:: Working closely with governments to write national plans and identify needs, and to match those needs with more than 600 partners and 74 donors through the COVID-19 Partners :: :: :: :: Sending expert missions to more than 130 countries to provide operational and technical support;
:: Sourcing, validating, purchasing and delivering masks, gloves, respirators, gowns, goggles, swabs, tests, reagents, thermometers, oxygen concentrators, ventilators and more, to 177 countries and territories;
:: Enrolling more than 12,000 patients in the WHO Solidarity Therapeutics Trial, in nearly 500 hospitals in 29 countries; and
:: Launching the Access to COVID-19 Tools Accelerator, which is working on diagnostics, treatment, vaccines and health system strengthening. It includes COVAX which is supporting the development of 9 vaccines, with more in the pipeline and aims to fairly distribute 2 billion vaccine doses by the end of 2021…